{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:04:40Z","timestamp":1781013880478,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Stroke is a rare but fatal complication of advanced cancer with Trousseau syndrome, especially as initial symptoms. Here, we report the clinical characteristics, treatment, and prognosis of patients with non-small cell lung cancer (NSCLC) who initially presenting with acute multiple cerebral infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical characteristics, imaging, treatment, and oncological outcomes of 10 patients diagnosed with Trousseau syndrome and NSCLC between 2015 and 2021 at Guangdong Sanjiu Brain Hospital were retrospectively collected and analyzed. The clinical course of two typical cases were presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All 10 patients with pathologically confirmed lung adenocarcinoma initially presented with neurological symptoms, including hemiplegic paralysis (7 patients, 70%), dizziness (5 patients, 50%), and unclear speech (3 patients, 30%). The median age was 63.5\u00a0years. Eight and two cases were stage III and IV, respectively, at the initial diagnosis. Five patients underwent driver gene testing, revealing three patients with EGFR-sensitive mutations, one patient with ALK fusion, and one patient with wild-type EGFR. All 10 patients received antiplatelet therapy, and six patients subsequently received anti-cancer treatment. The median overall survival of the patients was 8.5\u00a0months (95% confidence interval) and 1-year survival rate was 57.1%. Patients who received antitumor treatment, especially those harboring driver gene mutations and received tyrosine kinase inhibitors, had better neurological symptom recovery and superior oncological prognosis (median overall survival, not reached versus 7.4\u00a0months,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Trousseau syndrome, presenting as multiple cerebral infarctions, is a rare complication of lung adenocarcinoma. Both antiplatelet and antitumor treatment are recommended to achieve better neurological recovery and oncological prognosis in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-023-11627-2","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T17:01:22Z","timestamp":1699635682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Weiping","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changguo","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"6","key":"11627_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"11627_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","volume":"6","author":"P Prandoni","year":"2005","unstructured":"Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005;6(6):401\u201310.","journal-title":"Lancet Oncol"},{"key":"11627_CR3","doi-asserted-by":"crossref","unstructured":"Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P: Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Basel) 2018, 10(10).","DOI":"10.3390\/cancers10100380"},{"issue":"2","key":"11627_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/1358863X10388346","volume":"16","author":"S Sanon","year":"2011","unstructured":"Sanon S, Lenihan DJ, Mouhayar E. Peripheral arterial ischemic events in cancer patients. Vasc Med (London, England). 2011;16(2):119\u201330.","journal-title":"Vasc Med (London, England)"},{"issue":"4","key":"11627_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.thromres.2010.10.001","volume":"127","author":"M Di Nisio","year":"2011","unstructured":"Di Nisio M, Ferrante N, Feragalli B, De Tursi M, Iacobelli S, Cuccurullo F, Porreca E. Arterial thrombosis in ambulatory cancer patients treated with chemotherapy. Thromb Res. 2011;127(4):382\u20133.","journal-title":"Thromb Res"},{"issue":"3","key":"11627_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jjco\/hyv165","volume":"46","author":"S Ikushima","year":"2016","unstructured":"Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Trousseau\u2019s syndrome: cancer-associated thrombosis. Jpn J Clin Oncol. 2016;46(3):204\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"11627_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12885-022-09597-y","volume":"22","author":"H Yang","year":"2022","unstructured":"Yang H, Wen L, Pan Y, Shan C, Hong W, Wang H, Zhou C, Cai L, Zhou C. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC Cancer. 2022;22(1):580.","journal-title":"BMC Cancer"},{"issue":"2","key":"11627_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/bc.bc_1_18","volume":"4","author":"W Chen","year":"2018","unstructured":"Chen W, He Y, Su Y. Multifocal cerebral infarction as the first manifestation of occult malignancy: Case series of trousseau\u2019s syndrome and literature review. Brain Circ. 2018;4(2):65\u201372.","journal-title":"Brain Circ"},{"issue":"8","key":"11627_CR9","doi-asserted-by":"publisher","first-page":"9097","DOI":"10.1002\/cam4.5647","volume":"12","author":"R Nakamura","year":"2023","unstructured":"Nakamura R, Yamada T, Tanaka S, Sasada A, Shiotsu S, Tani N, Takeda T, Chihara Y, Hirai S, Takemura Y, et al. Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non-small cell lung cancer. Cancer Med. 2023;12(8):9097\u2013105.","journal-title":"Cancer Med"},{"issue":"3","key":"11627_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","volume":"5","author":"ME Tesselaar","year":"2007","unstructured":"Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5(3):520\u20137.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"11627_CR11","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1212\/01.WNL.0000163850.07976.63","volume":"64","author":"TG Jovin","year":"2005","unstructured":"Jovin TG, Boosupalli V, Zivkovic SA, Wechsler LR, Gebel JM. High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer. Neurology. 2005;64(11):1944\u20135.","journal-title":"Neurology"},{"issue":"1","key":"11627_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3892\/mco.2016.888","volume":"5","author":"M Ishikawa","year":"2016","unstructured":"Ishikawa M, Nakayama K, Ishibashi T, Sato E, Nakamura K, Katagiri H, Kyo S. Case series of cerebral infarction with Trousseau\u2019s syndrome associated with malignant gynecological tumors. Mol Clin Oncol. 2016;5(1):138\u201342.","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"11627_CR13","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s10637-020-00943-0","volume":"38","author":"K Nakashima","year":"2020","unstructured":"Nakashima K, Ozawa Y, Daga H, Imai H, Tamiya M, Tokito T, Kawamura T, Akamatsu H, Tsuboguchi Y, Takahashi T, et al. Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial. Invest New Drugs. 2020;38(6):1854\u201361.","journal-title":"Invest New Drugs"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11627-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T17:01:25Z","timestamp":1699635685000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11627-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11627"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11627-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2528570\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Guangdong Sanjiu Brain Hospital. All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all patients who still alive. For patients who had passed away, due to the retrospective, anonymous characteristics of this study, the requirement for written informed consent was waived with the agreement of the Guangdong Sanjiu Brain Hospital Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1096"}}